ClinicalTrials.gg
RecruitingNCT06393439VR-FMDUpdated Sep 29, 2025

Virtual Reality in Functional Movement Disorder

An interventional study of Virtual reality motor task in Functional Movement Disorder, sponsored by Medical University of Graz. Recruiting at 1 site in Austria. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-29.

Sponsored by Medical University of Graz · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study investigates the effect of virtual reality (VR) motor tasks on functional movement disorders.

Read the detailed description

The investigators want to investigate how different display modes of virtual hands and the experimental manipulation of the visual representation of virtual hand movements affect (1) the performance of the hand movements (2) the tremor and (3) the subjective perception of the tremor.

There are three groups: Patients with functional tremor (FT), patients with essential tremor (ET) and healthy controls (HC). The study is carried out on one or two consecutive days. The first appointment is only made for patients with ET and FT and is used for the neurological examination and to assess the severity of the tremor. It takes place at the Outpatient Clinic for Movement Disorders at the University Clinic for Neurology in Graz and lasts a maximum of 30 minutes. The second appointment is at the Institute of Psychology at the University of Graz and requires the active participation of the respondent for 2.5 hours. Subjects are asked not to take any tremor-influencing medication on the day of the examination. HC will only attend the appointment at the Institute of Psychology.

First appointment:

  • Clinical Global Impression - Severity Scale (CGI-S): 5-point Likert scale, clinicians assess the severity of the condition
  • Patient Global Impression of Severity (PGI-S): 5-point Likert scale, patients assess the severity of the condition
  • Fahn Tolosa Marin Tremor Rating Scale (FTM): assesses the tremor severity
  • Simplified Version of the Functional Movement Disorders Rating Scale (S-FMDRS): assesses the severity of the functional tremor

Second appointment:

  1. Questionnaires:

    • Simulator Sickness Questionnaire (SSQ): 4-point Likert scale, assesses nausea, oculomotor and visual disturbances, disorientation (2 timepoints: before and after VR tasks)
    • Edinburgh Handedness Inventory (EDI)
    • Questionnaire about sociodemographic data
    • Technology Usage Inventory (TUI): 7-point Likert scale, acceptance and use of technologies
    • Igroup Presence Questionnaire (IPQ): sense of presence in the VR
  2. electroencephalogram (EEG) and surface-Electromyography (surface-EMG) of forearm muscles: run synchronously with the examinations
  3. VR-tasks: all tasks are carried out in randomized order

    1. 3x3 matrix: individual fields light up in random order, participants are instructed to touch the fields in the given sequence as quickly as possible. 30 repetitions with a realistic VR-hand model and 30 repetitions with an abstract VR-hand model.
    2. 3x3 matrix: same task as (a) but after each repetition, participants must touch a field labeled "next" to continue the task. 30 repetitions.
    3. apple in a box: a virtual apple is to be placed in a virtual box using the hand with the weaker tremor, while the other hand is left resting on the table. 30 repetitions.
    4. apple in a box: same task as (c) but the resting hand is not visible. 30 repetitions.
02

Conditions studied

  • Functional Movement Disorder

Keywords

  • Tremor
  • Virtual Reality
  • Functional neurological disorder
03

In context

Conversion Disorder

89 studies on the registry are indexed under Conversion Disorder; 34 are open to participants now.

This study's planned enrollment of 48 is above the median of 38 across 51 interventional studies indexed under Conversion Disorder.

Browse Conversion Disorder studies →

Lead sponsor

Medical University of Graz is the lead sponsor of 471 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of functional tremor (FT) or essential tremor (ET) or healthy control persons
  • In patients with FT and ET: presence of a constant or intermittent tremor during the neurological examination

Exclusion criteria

Exclusion Criteria:

  • unclear tremor syndrome
  • essential tremor plus (ET plus)
  • conditions that interfere with EEG diagnostic (skin conditions, skin infections, wounds)
  • reflex epilepsy
  • cervical degeneration or chronic pain syndrome of the cervical spine
  • severe somatic illness
  • previous cerebral or head surgery
  • implanted pacemaker or deep brain stimulation
  • persons who are unable to consent
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Functional Movement Disorder

    Diagnostic Test: Virtual reality motor task

  • Experimental
    Essential Tremor

    Diagnostic Test: Virtual reality motor task

  • Experimental
    Healthy Control

    Diagnostic Test: Virtual reality motor task

Interventions

  • Diagnostic testVirtual reality motor task

    After a short practice task, participants perform motor tasks in a virtual reality environment. Reaction time is used to assess task performance.

06

What researchers measure

Primary outcomes

  1. Task performance

    Reaction time in processing the VR task, measured in seconds

    Time frame: 4 measurement points: abstract hand model without time pressure, abstract hand model with time pressure, realistic hand model without time pressure, realistic hand model with time pressure. Approximately 2.5 hours

Secondary outcomes

  1. Tremor duration

    Duration of tremor during the motor task, expressed as % of movement time (only in FT and ET)

    Time frame: 5 measurement points: tasks a, b, c, d; Approximately 2.5 hours

  2. EEG

    Changes in mu and beta event-related (de)synchronizations between motor tasks and right and left hemispheres

    Time frame: 10 measurement points: resting state before each motor task and during each motor task; Approximately 2.5 hours

  3. Subjective tremor severity on a visual analogue scale (VAS)

    Subjective tremor severity measured by a visual analogue scale (VAS) from 0 to 10 points, with higher scores indicating greater tremor severity

    Time frame: 6 measurement points: before and after each task; Approximately 2.5 hours

  4. VR acceptance

    Technology Usage Inventory (TUI): from 29 to 203 points, with higher scores indicating greater acceptance of technologies

    Time frame: 2 measurement points: before and after the VR examination, Approximately 2.5 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06393439
Responsible party
Sponsor
First posted
May 1, 2024
Start date
May 1, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
Sep 29, 2025

Study contacts

Daniela Kern, MD
Contact
daniela.eibl@medunigraz.at
004331638516051
Petra Schwingenschuh, MD
Contact
petra.schwingenschuh@medunigraz.at
004331638583379
Petra Schwingenschuh, MD
principal investigator · Medical University of Graz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion